Welcome to our dedicated page for GE Aerospace news (Ticker: GE), a resource for investors and traders seeking the latest updates and insights on GE Aerospace stock.
GE Aerospace reports news on its aircraft engine, services, and systems business, including commercial engine orders, long-term service support, maintenance, repair and overhaul investments, and digital tools used in production, supply chain, and military aircraft readiness. Coverage includes customer selections for GEnx and other GE Aerospace or CFM-powered fleets, dividend declarations, workforce-training initiatives, and governance matters involving defense-related products.
Ahead of its spinoff in January 2023, GE Healthcare introduced over 40 solutions at the RSNA 2022 Annual Meeting aimed at enhancing patient outcomes and healthcare efficiency. Emphasizing integrated data and analytics, the company addresses significant industry challenges, including rising costs and staff shortages. Key innovations include the SIGNA Experience, Revolution Apex CT platform, and various collaborations in precision oncology, positioning GE Healthcare as a leader in medical technology and personalized care.
GE announced the "Reference Yield" for its offer to purchase up to $7 billion of various securities as part of a Tender Offer. The aggregate principal amount of tendered securities is expected to exceed this maximum amount. The Offer to Purchase, which outlines the terms of the Tender Offer, is available online. Key details include applicable yields and acceptance priority levels for different security series. The Tender Offer's expiration date is set for December 7, 2022, and early participation offers a $50 bonus per $1,000 principal amount for securities tendered before the Early Participation Date.
GE has announced the results of its Tender Offer as of 5:00 p.m. on November 22, 2022, with approximately $9.3 billion in U.S. dollars, £629 million in Pounds Sterling, and €865 million in Euros validly tendered. The company intends to purchase up to $7 billion in securities; however, the total tendered may exceed this amount. The Tender Offer's Expiration Date is set for December 7, 2022. This offer allows GE to manage its debt obligations more effectively.
General Electric (GE) announced the successful closure of its offering of $1 billion 5.550% senior notes due 2024 and additional senior notes totaling $5.5 billion. These offerings are part of the financing for the planned spin-off of GE HealthCare, expected to finalize in early January 2023. The proceeds will go towards settling debt obligations linked to the spin-off. GE will be released from its guarantees upon completion of the transaction. GE HealthCare will become a standalone corporation, named GE HealthCare Technologies Inc..
GE Healthcare has launched an intelligent workload management solution for PACS, aimed at streamlining radiology workflows. This solution can boost interpretation production by up to 21% and significantly reduce scan time by 50%, enhancing patient care and clinician productivity. Key metrics show a 16.7% improvement in STAT turnaround time and a 20.5% enhancement in emergency departmental turnaround time. With radiologist shortages projected by 42,000 in the U.S. by 2033, these innovations are crucial to mitigate burnout and improve healthcare delivery.
GE Healthcare has announced an $80 million investment to expand its Active Pharmaceutical Ingredients facility in Lindesnes, location value="LC/no"Norway, by 30%. This initiative is aimed at producing an additional 30 million doses of iodinated contrast media annually by 2025, responding to expected global demand doubling over the next decade. The expansion is set to create around 100 new jobs and follows the recent opening of a new production line in Cork, Ireland. This investment reinforces GE Healthcare's leadership in the contrast media market.
General Electric (GE) announced the pricing of $8.25 billion in senior notes to fund the spin-off of GE HealthCare, expected to finalize in early January 2023. This includes various notes with due dates ranging from 2024 to 2052, featuring interest rates between 5.550% and 6.377%. The notes will be guaranteed by GE until the spin-off is completed. GE HealthCare aims to secure a strong investment-grade credit rating post-spin-off and will become GE HealthCare Technologies Inc.. The offering is aimed at institutional buyers under specific regulations.
Hyliion Holdings Corp. (NYSE: HYLN) reported its Q3 2022 financial results, generating $0.5 million in revenue and maintaining a cash position of over $455 million. The company closed the acquisition of the KARNO generator from GE Additive, enhancing its hydrogen-fuel capabilities. Hyliion announced its Founders Program for the first 200 Hypertruck ERX units and confirmed the trucks qualify for a 30% tax credit under the Inflation Reduction Act. The updated revenue guidance for 2022 is approximately $2 million, with operating expenses projected at $130 million.
GE (NYSE: GE) has announced a tender offer to purchase up to $7 billion in outstanding securities, part of its strategy to reduce debt as it moves towards creating three standalone companies, including GE HealthCare. The tender offer is set to expire on December 7, 2022, with an early participation date on November 22, 2022. Holders of the securities can receive total consideration that includes accrued interest. GE intends to use proceeds from new debt securities for debt repayment, supporting its leverage reduction efforts.
GE Healthcare’s DaTscan has received FDA approval for the diagnosis of Dementia with Lewy Bodies (DLB), expanding its established use in evaluating Parkinsonian syndromes. This marks a significant advancement, as DLB is often misdiagnosed, with up to 70% of cases mistaken for Alzheimer’s Disease. The expanded use of DaTscan aims to enhance diagnostic accuracy for one in five dementia patients suffering from DLB, potentially leading to better treatment paths. Over one million DaTscan doses have been administered globally, underscoring its market leadership in radiopharmaceutical diagnostics.